Lushi Tan
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Asymmetric Synthesis and Catalysis, HIV/AIDS drug development and treatment, Asymmetric Hydrogenation and Catalysis, Synthetic Organic Chemistry Methods
Most-Cited Works
- → Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor(1998)212 cited
- → A Novel, Highly Enantioselective Ketone Alkynylation Reaction Mediated by Chiral Zinc Aminoalkoxides(1999)185 cited
- → Rhodium‐Catalyzed Regioselective C7‐Functionalization of N‐Pivaloylindoles(2015)179 cited
- → Manufacturing Process Development for Belzutifan, Part 2: A Continuous Flow Visible-Light-Induced Benzylic Bromination(2021)87 cited
- → Dynamic Kinetic Resolution: Asymmetric Transfer Hydrogenation of α-Alkyl-Substituted β-Ketoamides(2009)77 cited
- → An Efficient Synthesis of an αvβ3 Antagonist(2004)70 cited